Beam Therapeutics Says Cash Runway Extends Into Mid-2029
Beam Therapeutics says its cash runway is expected to support operating plans into mid-2029.
Related stories
Balu Forge Begins 155mm Shell Dispatches and Secures New Orders
Balu Forge Industries says it has begun dispatching 152mm empty artillery shells and secured quality approval for 155mm extended-range full-bore shells. It also reports new orders
M impact | EQUITY | Nov 03, 2026, 05:32 PM UTC
Bata India Q2 Profit Rises 28.6% as EBITDA Margin Falls to 16.7%
Bata India reported consolidated Q2FY27 revenue of Rs 862 crore and net profit of Rs 18 crore, up from Rs 14 crore a year earlier. EBITDA margin fell to 16.7%.
M impact | EQUITY | Nov 03, 2026, 05:32 PM UTC
V-Mart Retail Q2 Loss Widens to Rs 16 Crore as Revenue Rises 18%
The retailer's EBITDA increased year on year to Rs 86.1 crore, with its margin improving marginally.
M impact | EQUITY | Nov 03, 2026, 05:32 PM UTC
Leap Partners Acquires 360 Plumbing Service in Richmond
Leap Partners acquired 360 Plumbing Service in the Richmond area, expanding its presence into Virginia.
M impact | EQUITY | Nov 03, 2026, 05:32 PM UTC
Magellan Copper & Gold Reports Third-Quarter Net Loss of $23.4K
The company reported a net loss of $23.4K for the third quarter of 2026, compared with a $153.3K loss a year earlier. Diluted loss per share was $(0.00), versus $(0.01).
M impact | EQUITY | Nov 03, 2026, 05:31 PM UTC
Ryman Hospitality Properties Reports Third-Quarter Revenue of $655.8 Million
Third-quarter 2026 revenue rose 10.7% year over year to $655.8 million. Net income available to common stockholders increased 15.3% to $40.2 million, and diluted EPS rose to $0.58
M impact | EQUITY | Nov 03, 2026, 05:31 PM UTC